Accueil・Liste d'Actions・Design Therapeutics Inc

Design Therapeutics Inc

Fermé

11.74 0.95

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

11.35

Max

12.06

Chiffres clés
By Trading Economics
Revenu	-1.6M -18M
BPA	-0.29
Employés	54
EBITDA	534K -17M

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+78.42% upside

Dividendes
By Acuity
Prochains Résultats	5 août 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	-59M 741M
Ouverture précédente	10.79
Clôture précédente	11.74

Design Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

23 juil. 2026, 23:52 UTC

Mexico's Q2 2026 GDP Growth Rate Release on July 30 Amid Cautious Economic Outlook and Market Volatility.

23 juil. 2026, 23:52 UTC

Germany's Inflation Rate Release on July 30, 2026 Sparks Market Speculation Amid Cooling Prices and Geopolitical Tensions.

23 juil. 2026, 23:52 UTC

Germany's July Inflation Rate Release Sparks Caution Among Investors Amid Rising Oil Prices and Geopolitical Tensions.

23 juil. 2026, 23:52 UTC

Japan's June inflation rises to 1.7%, but remains below Bank of Japan’s target, raising concerns over wage growth and global supply chain issues.

23 juil. 2026, 23:52 UTC

UK Consumer Confidence Index Improves to -17.0, Exceeding Expectations Amid Positive Market Sentiment and Geopolitical Concerns

23 juil. 2026, 23:52 UTC

Australia's S&P Global Manufacturing PMI rises to 51.7 in July, signaling continued growth amid inflationary pressures and increased hiring activity.

23 juil. 2026, 23:52 UTC

Australia's S&P Global Services PMI rises to 53.0 in July, signaling growth and boosting economic optimism despite global inflation concerns.

23 juil. 2026, 23:52 UTC

New Home Sales Expected at 610,000 Units Amid Rising Mortgage Rates and Declining Buyer Sentiment

23 juil. 2026, 23:52 UTC

Cautious Market Sentiment Ahead of U.S. New Home Sales Report Amid Rising Mortgage Rates and Declining Buyer Activity

23 juil. 2026, 23:52 UTC

Japan's Retail Sales Expected to Continue Growth Amid Strong Trade Data, but Inflation Concerns Loom Ahead of July 30 Release.

23 juil. 2026, 23:52 UTC

Japan's Industrial Production Faces Caution Ahead of July Release Amid Mixed Economic Signals and Rising Inflation.

23 juil. 2026, 23:52 UTC

The Nikkei 225 Index is trading lower in after-market hours, continuing its decline since Thursday. No specific news was identified to explain this move.

23 juil. 2026, 23:51 UTC

News

Cavco Industries Inc. announced its first-quarter earnings release date, contributing to positive investor sentiment. Shares are higher in after-market trading.

23 juil. 2026, 23:51 UTC

Woodward Inc. shares are lower in after-market trading, showing notable volatility with fluctuations between a high of 1.07% and a low of -1.01%.

23 juil. 2026, 23:51 UTC

Antero Resources Corp shares are higher in after-market trading, supported by rising crude oil prices amid inflation and interest rate concerns.

23 juil. 2026, 23:51 UTC

NewMarket Corp shares are lower in after-market hours, despite earlier gains. The stock is below its 20-day moving average amid inflation concerns.

23 juil. 2026, 23:51 UTC

Correlated Moves

Coeur Mining Inc shares are higher in after-market trading, aligning with a positive trend among gold-related equities amid broader market resilience despite bond market instability.

23 juil. 2026, 23:51 UTC

Xenon Pharmaceuticals Inc shares are lower in after-market hours, continuing a downward trend with no specific news identified to explain the decline.

23 juil. 2026, 23:51 UTC

Under Armour Inc shares are lower in after-market trading, reflecting significant selling pressure despite broader market resilience amid inflation concerns and rising crude oil prices.

23 juil. 2026, 23:51 UTC

Southern Co. shares declined after-market, following a volatile session amid broader market resilience and concerns over inflation and rising crude oil prices.

23 juil. 2026, 23:51 UTC

News

Scholastic Corp shares fell in after-market trading following fourth-quarter results, where revenue of $476.1 million missed expectations and net income dropped to $9.4 million.

23 juil. 2026, 23:51 UTC

Trustmark Corp shares are lower in after-market hours, remaining below their 20-day moving average amid broader market instability reflected in rising credit default swaps.

23 juil. 2026, 23:51 UTC

News

Social Media

Leidos Holdings shares are lower in after-market trading amid concerns over long-term revenue growth, despite a backlog of $48.37 billion.

23 juil. 2026, 23:51 UTC

RPM International Inc shares are lower in after-market hours, reflecting notable weakness since Thursday's close and positioning below the 20-day moving average.

23 juil. 2026, 23:51 UTC

Array Technologies Inc. shares declined after-market, continuing a downward trend since Thursday's close, despite an earlier session rebound from a cumulative low.

23 juil. 2026, 23:51 UTC

News

Codexis Inc announced a public offering of common stock, contributing to a notable decline in shares during after-market trading.

23 juil. 2026, 23:51 UTC

Tyson Foods Inc shares are lower in after-market trading, remaining near the lower end of their one-month range amid broader market instability.

23 juil. 2026, 23:51 UTC

Spero Therapeutics Inc. shares are lower in after-market hours, continuing a downward trend after five consecutive sessions of declines.

23 juil. 2026, 23:51 UTC

Fidelity National Information Services shares are higher in after-market trading, despite earlier session declines and a lack of specific news to explain the movement.

23 juil. 2026, 23:51 UTC

American Water Works shares are higher in after-market trading, continuing positive momentum after three consecutive gains and positioning above the 20-day moving average.

Comparaison

Variation de prix

Design Therapeutics Inc prévision

Objectif de Prix

By TipRanks

78.42% hausse

Prévisions sur 12 Mois

Moyen 20.75 USD 78.42%

Haut 22 USD

Bas 20 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

Achat

Maintien

Vente

Basé sur 5 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.